Viewing Study NCT00863967


Ignite Creation Date: 2025-12-25 @ 12:33 AM
Ignite Modification Date: 2026-03-02 @ 4:02 PM
Study NCT ID: NCT00863967
Status: UNKNOWN
Last Update Posted: 2009-03-18
First Post: 2009-03-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Early Detection of Arteriosclerosis
Sponsor: Kantonsspital Baselland Bruderholz
Organization:

Study Overview

Official Title: Prospective Observational Cohort Study for Early Detection of Arteriosclerosis
Status: UNKNOWN
Status Verified Date: 2009-03
Last Known Status: ACTIVE_NOT_RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Arteriosclerosis is a common chronic disease with well known risk factors like diabetes mellitus, hypertension, dyslipidemia, adipositas and smoking, leading to severe complications like myocardial infarction, stroke or peripheral arterial occlusive disease. In addition to life-style factors there is also a genetic predisposition to develop complicated atherosclerosis.

Objective: Improve individual risk prediction by clinical phenotyping and genotyping.
Detailed Description: About 300 patients who are treated for various conditions at the department of general medicine at our hospital will be included prospectively in the study. This observational cohort will be followed for at least 10 years follow-up examinations.

At baseline and during follow up visits detailed clinical phenotyping is planned (medical and family history,standardized clinical and physical examinations, lab, RX, ECG, stress-test or echocardiogram). The genotyping is performed by DNA-isolation from leucocytes collected at baseline.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: